Plain-English translation of NCT06280755 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study is collecting medical information and brain imaging data from people with multiple sclerosis and similar conditions. Researchers will use artificial intelligence to analyze this data and create tools that help doctors better predict how the disease will progress in individual patients and choose the most effective treatments for each person.
Many people with multiple sclerosis need better, more personalized treatment plans to slow disease progression and prevent long-term disability. This study aims to use advanced AI and brain imaging data to help doctors understand which patients are getting worse due to disease activity versus other causes, so they can make smarter treatment choices tailored to each person.
You likely qualify if…
You likely don't qualify if…
You won't need to visit a clinic or take any new medication. Instead, researchers will access your existing medical records and brain imaging scans from your regular MS care at participating hospitals. The study is retrospective, meaning it looks back at data already collected during your normal treatment. No additional appointments or procedures are required from you as a participant.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Czechia
Germany